{
    "clinical_study": {
        "@rank": "159822", 
        "acronym": "UTROGESTAN", 
        "arm_group": [
            {
                "arm_group_label": "Utrogestan", 
                "arm_group_type": "Active Comparator", 
                "description": "oral tablet Utrogestan 400mg daily for 2 days"
            }, 
            {
                "arm_group_label": "Nifedipine", 
                "arm_group_type": "Placebo Comparator", 
                "description": "tablet Nifedipine 20 mg stat then 20 mg after 30 minutes then another 20 mg after 30 minutes followed by 10 mg three times daily for 2 days"
            }
        ], 
        "brief_summary": {
            "textblock": "RESEARCH HYPOTHESIS\n\n      -Incidence of preterm delivery is lower in women treated with oral micronized progesterone\n      (Utrogestan) as acute tocolysis agent compare to Nifedipine group with fewer maternal side\n      effect"
        }, 
        "brief_title": "Utrogestan Versus Nifedipine as Tocolysis for Preterm Labor: a Randomised Controlled Trial", 
        "completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Preterm Labor", 
        "condition_browse": {
            "mesh_term": "Obstetric Labor, Premature"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        \u2022 Singleton pregnancy women between 22 and 34 weeks of gestation who presented with\n        threatened preterm labor.\n\n        Exclusion Criteria:\n\n          -  Multiple pregnancies\n\n          -  Women with Preterm Prelabour Rupture of Membrane\n\n          -  Fetal death\n\n          -  Women with bad obstetric history\n\n          -  Women with history of cervical incompetence\n\n          -  Contraindication to Nifedipine such as cardiovascular disease, hyperthyroidism,\n             severe pre eclampsia or to Utrogestan\n\n          -  Maternal or fetal indication for immediate delivery, such as fetal distress, bleeding\n             placenta previa, abruption placenta\n\n          -  Contraindication for tocolysis, for example severe pre eclampsia, intrauterine growth\n             restriction, fetal anomaly, chorioamnionitis, significant antepartum haemorrhage\n\n          -  Cervical dilatation of  3cm or more\n\n          -  Patients with previous tocolytic treatment during this pregnancy\n\n          -  Women who refuse to participate in this study"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "50 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "32", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 4, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01985594", 
            "org_study_id": "FF-2013-407"
        }, 
        "intervention": [
            {
                "arm_group_label": "Utrogestan", 
                "description": "Oral Tablet Utrogestan 400 mg daily for 2 days", 
                "intervention_name": "utrogestan", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Nifedipine", 
                "description": "Tablet Nifedipine 20 mg stat then 20 mg after 30 minutes if contraction persist and another 20mg after 30 minutes if contraction still persist followed by 10 mg three times daily for 2 days", 
                "intervention_name": "Nifedipine", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Nifedipine", 
                "Progesterone"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": "preterm labor", 
        "lastchanged_date": "November 10, 2013", 
        "location": {
            "contact": {
                "last_name": "national university of malaysia medical centre", 
                "phone": "60391455950"
            }, 
            "facility": {
                "address": {
                    "city": "Cheras", 
                    "country": "Malaysia", 
                    "state": "Kuala Lumpur", 
                    "zip": "56000"
                }, 
                "name": "Obstetric and Gynaecology Department, National University of Malaysia Medical Centre"
            }, 
            "investigator": [
                {
                    "last_name": "nor zila hassan malek", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "nor azlin mohamed ismail", 
                    "role": "Principal Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Malaysia"
        }, 
        "number_of_arms": "2", 
        "official_title": "STUDY ON EFFICACY OF UTROGESTAN AS TOCOLYSIS FOR PRETERM LABOR", 
        "overall_contact": {
            "email": "nzhm_dr@yahoo.com", 
            "last_name": "nor zila hassan malek", 
            "phone": "60139823219"
        }, 
        "overall_official": {
            "affiliation": "National University of Malaysia", 
            "last_name": "nor azlin mohamed ismail", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Malaysia: Ministry of Health", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "delivery less than 24 hours of tocolysis,delivery less than 48 hours of tocolysis, delivery less than 7 days of tocolysis", 
            "measure": "latency period interval between time of tocolysis and delivery", 
            "safety_issue": "Yes", 
            "time_frame": "24 hours up to 7 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01985594"
        }, 
        "responsible_party": {
            "investigator_affiliation": "National University of Malaysia", 
            "investigator_full_name": "nor zila hassan malek", 
            "investigator_title": "medical officer", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "delivery less than 34 weeks of gestation, delivery more than or at 34 weeks of gestation", 
                "measure": "Pregnancy outcomes", 
                "safety_issue": "Yes", 
                "time_frame": "34 weeks of gestational age"
            }, 
            {
                "description": "Birth weight (kg),cord blood acidity, need for neonatal intensive care unit admission", 
                "measure": "Neonatal outcome", 
                "safety_issue": "Yes", 
                "time_frame": "24 hours"
            }, 
            {
                "description": "Palpitation,Headache, Nausea/Vomiting, Hypotension, Dyspnea, Jaundice, Pruritus", 
                "measure": "Maternal side effect", 
                "safety_issue": "Yes", 
                "time_frame": "30 minutes up to 48 hours"
            }
        ], 
        "source": "National University of Malaysia", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "nor zila hassan malek", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "November 2013"
    }
}